What Does Chlamydia Look Like? Symptoms, Signs, and Testing

To recognize what chlamydia looks like, understand that the infection usually looks like nothing at all. Chlamydia trachomatis is an intracellular bacterium that lives inside the cells of the genital tract, producing no visible signs in up to 70 percent of women and roughly 50 percent of men while continuing to damage reproductive tissue. Routine laboratory testing remains the only reliable way to confirm your status, since self-examination cannot reveal the bacteria.

This guide covers the often-invisible nature of chlamydia, detailing the subtle symptoms it can produce in men and women and walking through why relying on appearance alone is risky for anyone sexually active.

The Quiet Infection Most People Never See Coming

Chlamydia trachomatis infiltrates the mucous membranes of the cervix, urethra, rectum, or throat and replicates inside those cells. Unlike gonorrhea or trichomoniasis, it rarely triggers dramatic inflammation, so your immune system often responds quietly. A man may notice only a slightly cloudy urine stream; a woman may mistake light spotting for the tail end of her period.

The absence of symptoms carries a serious implication: silence does not equal clearance. The bacteria keep colonizing reproductive tissue, and in women, untreated infection can ascend into the uterus and fallopian tubes. Because asymptomatic carriers still transmit the bacteria through sexual contact, annual screening for sexually active women under 25 and older women with risk factors such as new or multiple partners is standard practice.

“Up to 70 percent of infected women and 50 percent of infected men show no visible symptoms at all. The only way to confirm the infection is through laboratory testing, not self-examination.

Why “No Symptoms” Doesn’t Mean “No Risk”

Pelvic inflammatory disease, infertility, and chronic pelvic pain can develop silently over months or years. Each round of untreated infection compounds the damage, and the body’s lack of warning signs is exactly what makes chlamydia so effective at spreading. Routine screening is the safety net that catches what your eyes cannot.

What Symptomatic Chlamydia Actually Looks Like

When chlamydia does produce visible signs, abnormal genital discharge is the most recognizable clue. In men, discharge often appears thin, watery, or slightly cloudy at the urethral opening, sometimes only noticeable in the morning before urination. In women, discharge tends to be mucopurulent with a yellow or green-tinged hue, distinct from normal clear cervical mucus. Both sexes may notice a faintly unusual odor that wasn’t present before exposure.

Pain during or after urination is another hallmark, reflecting inflammation of the urethra (urethritis) or cervix (cervicitis). Women sometimes describe a burning sensation similar to a urinary tract infection, which is exactly why so many cases get misdiagnosed at first. Pelvic aching, lower abdominal discomfort, or pain during intercourse can signal that the infection has begun moving upward into the upper reproductive tract.

Signs Unique to Each Sex

Men should pay particular attention to testicular tenderness or swelling, which may indicate epididymitis, an inflammation of the sperm-carrying duct that can affect fertility if untreated. Women may notice spotting between periods, heavier-than-usual bleeding, or postcoital bleeding that seems to come from nowhere. Throat infections from oral exposure often produce no symptoms, though some people report a persistent sore throat or swollen lymph nodes.

Rectal infections can cause anal discharge, bleeding, or tenesmus, that uncomfortable sensation of needing to pass stool even when the bowels are empty.

Men vs Women: How Presentation Differs

Biological anatomy shapes how the infection announces itself. Men typically develop urethritis within one to three weeks of exposure, marked by clear or whitish penile discharge, a burning sensation during urination, and occasionally itching at the urethral opening. Women develop cervicitis, which often produces yellow cervical mucus, postcoital bleeding, and a friable cervix that bleeds easily on contact during a pelvic exam.

Symptom overlap with gonorrhea, urinary tract infections, and vaginal yeast infections makes clinical or laboratory confirmation essential. A woman who assumes she has a UTI and self-treats with over-the-counter products may be ignoring a chlamydia infection that keeps progressing. The same caution applies to men who dismiss mild discharge as “nothing.”

When the Infection Spreads Beyond the Genitals

Rectal chlamydia can develop from anal intercourse or, in women, from perineal spread. Throat chlamydia results from oral-genital contact. Both sites frequently remain asymptomatic, though rectal infections occasionally produce discharge, pain, or bleeding that mimics other anorectal conditions. Co-testing at multiple exposure sites is standard practice when a patient reports contact at those locations.

Why Visual Inspection Alone Is Never Enough

Chlamydia bacteria measure roughly 0.3 micrometers across, far below the resolution of the naked eye. No mirror, magnifying glass, or smartphone camera can confirm the infection. Even an experienced clinician examining your cervix or urethra visually cannot diagnose chlamydia based on appearance alone, because the inflammation it produces looks identical to gonorrhea, trichomoniasis, or bacterial vaginosis.

“A visual match is a hypothesis, not a diagnosis. Confirming chlamydia requires a laboratory test that detects bacterial DNA or antigens.

The gold standard is nucleic acid amplification testing (NAAT), which can identify chlamydia genetic material from a urine sample, a vaginal swab, or a urethral swab. Results typically return within 24 to 72 hours. Because coinfection rates with gonorrhea run between 10 and 30 percent in some populations, co-testing for both pathogens is routine. Screening for HIV and syphilis often accompanies STI panels, since risk behaviors overlap.

Common Myths Worth Dismissing

• ▸Myth: You can tell by looking at discharge color.
• ▸Fact: Discharge color overlaps with gonorrhea, yeast infections, and normal variations.
• ▸Myth: If symptoms disappear, the infection cleared on its own.
• ▸Fact: Untreated chlamydia can become asymptomatic while continuing to damage tissue.
• ▸Myth: Urinating after sex flushes out the bacteria.
• ▸Fact: Post-exposure urination does not eliminate intracellular colonization.
• ▸Myth: A negative visual exam rules out infection.
• ▸Fact: Most infections produce no visible signs at any stage.

What Happens After Diagnosis and Treatment

Once a NAAT confirms chlamydia, current CDC guidelines recommend antibiotic therapy to eliminate the infection. Your provider’s specific regimen will depend on your medical history, pregnancy status, and local resistance patterns. Sexual partners from the past sixty days should be notified, tested, and treated to prevent reinfection cycles. Expedited partner therapy, where a provider prescribes or dispenses medication for a partner without examining them, is legal in most U.S. states and supported by public health authorities.

Abstaining from sexual activity for seven days after completing treatment prevents transmission to the next step in your sexual network. A test-of-cure visit is not typically required for uncomplicated genital infections, but retesting at three months is strongly recommended. Reinfection rates climb as high as 20 percent in some age groups, particularly among adolescents and young adults, partly because partner notification and treatment don’t always happen.

Follow-Up Checklist

• ▸Complete the full course: Stopping antibiotics early can allow resistant bacteria to survive.
• ▸Notify recent partners: Anyone you’ve had sexual contact with in the past two months needs testing.
• ▸Abstain for seven days: After finishing the prescribed regimen, avoid sexual activity for that week.
• ▸Retest at three months: A follow-up NAAT catches reinfection that may have occurred.
• ▸Repeat screening annually: Women under 25 and others at elevated risk benefit from yearly testing.

The Real Risks of Leaving Chlamydia Untreated

Untreated chlamydia in women can progress to pelvic inflammatory disease, a serious infection of the uterus, fallopian tubes, and surrounding tissue. PID develops in roughly 10 to 15 percent of women with untreated cervical chlamydia, and even one episode can scar the fallopian tubes permanently.

That scarring raises the lifetime risk of ectopic pregnancy, a potentially life-threatening condition where a fertilized egg implants outside the uterus, and tubal-factor infertility, which accounts for a substantial share of infertility cases diagnosed in reproductive-age women.

Men face their own complications. Epididymitis, inflammation of the coiled tube at the back of the testicle, can cause severe scrotal pain, swelling, and in rare cases, impaired sperm production. Reactive arthritis, sometimes called Reiter’s syndrome, is a less common downstream effect that produces joint pain, eye inflammation, and urinary symptoms, sometimes months after the initial infection clears.

“Consistent condom use lowers transmission risk substantially without eliminating it entirely. Skin-to-skin contact with infected areas not covered by a condom can still transmit the bacteria.

The Bottom Line on Long-Term Consequences

Chronic pelvic pain, infertility, and ectopic pregnancy are documented outcomes that follow untreated infection in a meaningful percentage of cases. Prompt testing and completing prescribed antibiotics can prevent virtually all of these complications. A single course of treatment typically resolves the infection, and follow-up testing confirms clearance.

Bottom Line

Chlamydia rarely looks like anything at all, and that invisibility is the single biggest reason it remains the most reported bacterial STI in the country. Testing, not visual inspection, is the only reliable path to diagnosis. Completing prescribed antibiotics and notifying recent partners are the steps that protect your long-term reproductive health.

FAQ